U.S. Ebola Case Gets Experimental Drug
While Spain gets its first infection.

Get the Beast Digest newsletter delivered straight to your inbox
By clicking “SIGN UP” you agree to our Terms of Use and Privacy Policy.
The Liberian Ebola patient in Dallas is in critical but stable condition, and will now be getting an experimental treatment. Dallas Presbyterian Hospital announced Monday it will administer a drug called brincidofovir. It's made by Chimerix, a biopharmaceutical company that specializes in oral antivirals for diseases with high unmet medical need. The drug was being developed for smallpox and adenovirus. Meanwhile, a nurse treating an Ebola victim in Spain has now tested positive for the virus. She is the first person in the current outbreak known to have become infected outside of Africa. She was part of the team that treated Spanish priest Manuel Garcia Viejo, who died from the virus in Spain after working in Africa.
Unlock a year of full access to The Daily Beast for $35.
Monthly
$1
First month then $5.99/month
Annual
$35
First year then $59.99/year
Premium
$79
First year then $119.99/year
*Substack access provided by the next business day, using your subscription email. Choosing the Premium plan constitutes your permission to share your subscription email with Substack and your agreement to Substack’s Privacy Policy.
Looks like you already have a subscription!
- Account (completed)
- Payment (completed)
- Confirmation (completed)
You're all set!
Thanks for subscribing.
- 1Account
- 2Payment
- 3Confirmation
Sign in or create an account
Register below to read this article for free or subscribe
to unlock unlimited access to The Daily Beast.
Monthly
$1
First month then $5.99/month
Annual
$35
First year then $59.99/year
Premium
$79
First year then $119.99/year
*Substack access provided by the next business day, using your subscription email. Choosing the Premium plan constitutes your permission to share your subscription email with Substack and your agreement to Substack’s Privacy Policy.
Already have an account? Sign In
Looks like you already have a subscription!
- Account (completed)
- Payment (completed)
- Confirmation (completed)
You're all set!
Thanks for subscribing.
- 1Account
- 2Payment
- 3Confirmation